Melanoma Research Review, Issue 20

In this issue:

Longer follow-up confirmed RFS benefit with dabrafenib plus trametinib
Sunscreen use and melanoma risk among young Australian adults
Risk of skin cancer in patients with HIV
Factors impacting on first-line treatment decisions for BRAF-mutated melanoma
Patient’s surgical treatment preferences of facial melanomas
A predictive scoring model for dermoscopy of SMIS
Risk of subsequent CM in moderately dysplastic nevi with positive histologic margins
NLR predicts worse outcome in metastatic BRAF-positive melanoma treated with BRAFi/MEKi
Immune checkpoint inhibitor therapy in combination with denosumuab in malignant melanoma
Neoadjuvant vs adjuvant ipilimumab + nivolumab in macroscopic stage III melanoma

Please login below to download this issue (PDF)

Subscribe